Intravenous injection of metallic mercury: case report and course of mercury during chelation therapy with DMPS

Clin Toxicol (Phila). 2008 Jul;46(6):566-9. doi: 10.1080/15563650701725102.

Abstract

Introduction: Although several cases of i.v. injection of metallic mercury have been reported, it still remains an uncommon event.

Case report: A 34-year-old male came to hospital because complaining of pleuritic chest pain. X-ray showed radio dense punctate lesions in both lung fields, as well as around both elbows. Mercury concentration in blood (140 microg/L) and urine (320 microg/L) from the patient were significantly elevated, compared with the reference concentrations of < or = 2.0 mug/L mercury in blood and urine. The course of renal elimination of mercury and the mercury concentration in whole blood during 5 months of chelation therapy with sodium 2,3-dimercapto-1-propanesulfonate (Dimaval) were monitored. Furthermore, the time-course of mercury in scalp hair from the patient was determined.

Conclusion: We report a case of probable consecutive i.v. administration of metallic mercury.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antidotes / therapeutic use*
  • Chelating Agents / therapeutic use*
  • Chest Pain / etiology
  • Elbow
  • Hair / metabolism
  • Humans
  • Injections, Intravenous
  • Lung / metabolism
  • Male
  • Mercury / administration & dosage*
  • Mercury / pharmacokinetics
  • Mercury / toxicity
  • Mercury Poisoning*
  • Tissue Distribution
  • Unithiol / therapeutic use*
  • X-Rays

Substances

  • Antidotes
  • Chelating Agents
  • Unithiol
  • Mercury